Trade Summary

6 days ago, Foff Erin Pennock, serving as Chief Medical Officer at MapLight Therapeutics, Inc. (MPLT), sold 47,158 shares at $36.78 per share, for a total transaction value of $1,734,490.12. Following this transaction, Foff Erin Pennock now holds 298,901 shares of MPLT.

This sale represents a 13.63% decrease in Foff Erin Pennock's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, July 18, 2026 (accepted Jul 17, 9:43 PM ET), 3 days after the trade was made.

MapLight Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.